Scientific Index

Overview:This randomized, double-blind, placebo-controlled study assessed the safety and effectiveness of a nasal spray combining ipratropium bromide (an anticholinergic agent) and xylometazoline (a decongestant) in treating rhinorrhea and nasal congestion...

Overview:This randomized, double-blind, placebo-controlled study investigated the efficacy and safety of combining ipratropium bromide nasal spray 0.03% (an anticholinergic agent) with beclomethasone dipropionate nasal spray (a corticosteroid) in patients with...

Overview:This systematic review and meta-analysis examined the cognitive effects of individual anticholinergic (AC) medications, given that anticholinergics are widely prescribed and concerns about cognitive side effects have produced mixed findings....

Overview:This open-label, 12-month clinical trial evaluated the long-term safety and efficacy of ipratropium bromide nasal spray 0.06% (84 mcg per nostril, three times daily) in patients with perennial allergic rhinitis...

Overview:This multicenter, randomized, double-blind clinical trial evaluated the efficacy and safety of ipratropium bromide nasal spray in treating rhinorrhea (runny nose) associated with perennial allergic rhinitis (PAR). A total of...

Overview:This systematic review and meta-analysis evaluated the impact of saline nasal irrigation (SNI) as an adjunctive treatment for allergic rhinitis (AR) across multiple patient groups. It focused on primary outcomes...